Related Experiment Video
Updated: Dec 11, 2025
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series
Kim C Ohaegbulam1, Mohamed Swalih, Pranavkumar Patel
1Department of Medicine, Long Island Jewish Forest Hills Hospital, Forest Hills, NY.
Insights
Vitamin D supplementation may help COVID-19 patients with acute respiratory distress syndrome. High-dose vitamin D improved recovery and reduced inflammation in deficient patients.
Area of Science:
- Immunology
- Endocrinology
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) is linked to acute respiratory distress syndrome (ARDS), disproportionately affecting minority communities.
- Elevated proinflammatory cytokines are associated with worse COVID-19 outcomes.
- Vitamin D receptor activation can reduce inflammatory cytokine secretion.
Purpose of the Study:
- To investigate the significance of the vitamin D pathway in COVID-19 patients.
- To explore vitamin D supplementation as a therapeutic innovation for COVID-19.
Main Methods:
- A case series involving 4 vitamin D deficient patients diagnosed with COVID-19.
- Patients received either standard (1000 IU/day) or high-dose (50,000 IU/day for 5 days) vitamin D supplementation.
Main Results:
- High-dose vitamin D supplementation normalized vitamin D levels.
- Clinical recovery was improved, indicated by shorter hospital stays and reduced oxygen needs.
- A reduction in inflammatory markers was observed in patients receiving high-dose vitamin D.
Conclusions:
- Vitamin D supplementation may be a cost-effective strategy to mitigate ARDS in underserved populations.
- Further randomized clinical trials are needed to validate the efficacy of vitamin D for COVID-19 treatment.
Background:
Coronavirus disease 2019 (COVID-19) has infected more than 4.4 million people and caused more than 300,000 deaths partly through acute respiratory distress syndrome with propensity to affect African American and Hispanic communities disproportionately. Patients with worse outcomes have exhibited higher blood plasma levels of proinflammatory cytokines. Activation of the vitamin D receptor expressed on immune cells has been shown to directly reduce the secretion of inflammatory cytokines, such as interleukin-6, and indirectly affect C-reactive protein.
Areas Of Uncertainty:
The significance of the vitamin D pathway in patients diagnosed with COVID-19.
Therapeutic Innovation:
Vitamin D supplementation in patients after diagnosis of COVID-19.
Patients And Pharmacological Interventions:
We report 4 vitamin D deficient patients diagnosed with COVID-19 in April 2020 who were provided with either cholecalciferol of 1000 IU daily (standard dose) or ergocalciferol 50,000 IU daily for 5 days (high dose) as part of supplementation.
Clinical Outcomes:
Patients that received a high dose of vitamin D supplementation achieved normalization of vitamin D levels and improved clinical recovery evidenced by shorter lengths of stay, lower oxygen requirements, and a reduction in inflammatory marker status.
Conclusions:
Vitamin D supplementation may serve as a viable alternative for curtailing acute respiratory distress syndrome in patients in underserved communities where resources to expensive and sought-after medications may be scarce. Randomized clinical trials will serve as an appropriate vessel to validate the efficacy of the therapeutic regimen and dissection of the pathway.
Related Concept Videos
01:23Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
01:22Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
01:24Chronic Kidney Disease II: Clinical Manifestations
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment: